Want to see SURG full AI Analyst Report?
SurgePays (SURG) Ratios
SurgePays Ratios
SURG's free cash flow for Q2 2026 was $-2.63M. For the 2026 fiscal year, SURG's free cash flow was increased by $0.00 and operating cash flow was $-2.63M. See a summary of the company’s cash flow.
| Ratios | Mar 26 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 0.38 | 2.95 | 2.63 | 1.17 | 1.39 |
| Quick Ratio | 0.37 | 2.66 | 1.91 | 0.70 | 0.95 |
| Cash Ratio | 0.10 | 1.95 | 1.15 | 0.30 | 0.63 |
| Solvency Ratio | -1.46 | -5.10 | 1.61 | 0.01 | -0.79 |
| Operating Cash Flow Ratio | -1.17 | -3.52 | 0.81 | 0.03 | -1.53 |
| Short-Term Operating Cash Flow Coverage | -2.79 | -12.61 | 2.24 | 0.30 | -9.10 |
| Net Current Asset Value | $ -16.94M | $ 9.16M | $ 19.84M | $ -1.32M | $ -2.06M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 1.59 | 0.19 | 0.13 | 0.24 | 0.39 |
| Debt-to-Equity Ratio | -0.88 | 0.30 | 0.19 | 1.63 | 2.16 |
| Debt-to-Capital Ratio | -7.46 | 0.23 | 0.16 | 0.62 | 0.68 |
| Long-Term Debt-to-Capital Ratio | -0.58 | 0.13 | 0.02 | 0.50 | 0.61 |
| Financial Leverage Ratio | -0.55 | 1.57 | 1.48 | 6.81 | 5.49 |
| Debt Service Coverage Ratio | -3.42 | -19.65 | 4.31 | 0.52 | -0.55 |
| Interest Coverage Ratio | -17.03 | -75.39 | 31.65 | 0.32 | -0.80 |
| Debt to Market Cap | 0.40 | 0.12 | 0.05 | 0.09 | 0.81 |
| Interest Debt Per Share | 0.78 | 0.27 | 0.42 | 0.81 | 3.47 |
| Net Debt to EBITDA | -0.36 | 0.17 | -0.46 | 0.45 | -0.27 |
| Profitability Margins | |||||
| Gross Profit Margin | -18.59% | -23.53% | 25.99% | 11.08% | 12.08% |
| EBIT Margin | -59.80% | -69.83% | 13.84% | 1.16% | -11.78% |
| EBITDA Margin | -57.85% | -67.71% | 14.64% | 1.97% | -9.98% |
| Operating Profit Margin | -59.93% | -68.63% | 13.76% | 0.52% | -11.74% |
| Pretax Profit Margin | -63.32% | -70.74% | 13.40% | -0.46% | -26.50% |
| Net Profit Margin | -63.32% | -75.11% | 15.03% | -0.56% | -26.50% |
| Continuous Operations Profit Margin | -63.32% | -75.45% | 15.05% | -0.46% | -26.50% |
| Net Income Per EBT | 100.00% | 106.18% | 112.18% | 123.05% | 100.00% |
| EBT Per EBIT | 105.66% | 103.08% | 97.43% | -87.29% | 225.80% |
| Return on Assets (ROA) | -423.56% | -190.73% | 49.18% | -2.00% | -69.39% |
| Return on Equity (ROE) | 234.18% | -298.57% | 72.99% | -13.64% | -381.02% |
| Return on Capital Employed (ROCE) | 352.86% | -233.21% | 64.56% | 6.01% | -63.07% |
| Return on Invested Capital (ROIC) | 1874.92% | -210.45% | 55.74% | 4.79% | -53.35% |
| Return on Tangible Assets | -468.64% | -238.14% | 54.85% | -2.33% | -89.02% |
| Earnings Yield | -107.54% | -134.37% | 22.42% | -0.84% | -152.88% |
| Efficiency Ratios | |||||
| Receivables Turnover | 14.08 | 20.29 | 14.38 | 13.17 | 15.71 |
| Payables Turnover | 6.61 | 19.14 | 15.76 | 18.68 | 6.04 |
| Inventory Turnover | 198.93 | 42.22 | 11.22 | 9.66 | 10.30 |
| Fixed Asset Turnover | 79.45 | 52.67 | 182.93 | 113.09 | 74.31 |
| Asset Turnover | 6.69 | 2.54 | 3.27 | 3.57 | 2.62 |
| Working Capital Turnover Ratio | 189.76 | 3.75 | 11.08 | 30.41 | -10.05 |
| Cash Conversion Cycle | -27.46 | 7.56 | 34.76 | 45.96 | -1.80 |
| Days of Sales Outstanding | 25.92 | 17.99 | 25.38 | 27.72 | 23.23 |
| Days of Inventory Outstanding | 1.83 | 8.65 | 32.53 | 37.78 | 35.44 |
| Days of Payables Outstanding | 55.22 | 19.07 | 23.16 | 19.54 | 60.47 |
| Operating Cycle | 27.75 | 26.63 | 57.91 | 65.50 | 58.68 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -1.06 | -1.11 | 0.72 | 0.06 | -3.49 |
| Free Cash Flow Per Share | -1.06 | -1.14 | 0.70 | 0.01 | -3.50 |
| Dividend Paid and CapEx Coverage Ratio | -1145.41 | -41.13 | 36.57 | 1.14 | -297.39 |
| Capital Expenditure Coverage Ratio | -1145.41 | -41.13 | 36.57 | 1.14 | -297.39 |
| Operating Cash Flow Coverage Ratio | -1.57 | -4.64 | 1.89 | 0.10 | -1.99 |
| Operating Cash Flow to Sales Ratio | -0.37 | -0.35 | 0.08 | 0.01 | -0.30 |
| Free Cash Flow Yield | -63.54% | -64.14% | 10.88% | 0.12% | -173.31% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -0.93 | -0.74 | 4.46 | -119.44 | -0.65 |
| Price-to-Sales (P/S) Ratio | 0.59 | 0.56 | 0.67 | 0.67 | 0.17 |
| Price-to-Book (P/B) Ratio | -2.18 | 2.22 | 3.26 | 16.29 | 2.49 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -1.57 | -1.56 | 9.19 | 858.73 | -0.58 |
| Price-to-Operating Cash Flow Ratio | -1.58 | -1.60 | 8.94 | 102.50 | -0.58 |
| Price-to-Earnings Growth (PEG) Ratio | 0.04 | 0.00 | -0.00 | 1.22 | 0.02 |
| Enterprise Value Multiple | -1.38 | -0.65 | 4.12 | 34.41 | -2.01 |
| Enterprise Value | 45.39M | 26.83M | 82.79M | 82.39M | 10.25M |
| EV to EBITDA | -1.38 | -0.65 | 4.12 | 34.41 | -2.01 |
| EV to Sales | 0.80 | 0.44 | 0.60 | 0.68 | 0.20 |
| EV to Free Cash Flow | -2.13 | -1.23 | 8.27 | 870.09 | -0.67 |
| EV to Operating Cash Flow | -2.13 | -1.26 | 8.05 | 103.86 | -0.67 |
| Tangible Book Value Per Share | -0.81 | 0.55 | 1.69 | 0.02 | -0.17 |
| Shareholders’ Equity Per Share | -0.77 | 0.80 | 1.98 | 0.40 | 0.81 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.00 | -0.07 | -0.12 | 0.00 | 0.00 |
| Revenue Per Share | 2.84 | 3.18 | 9.62 | 9.81 | 11.65 |
| Net Income Per Share | -1.80 | -2.39 | 1.45 | -0.05 | -3.09 |
| Tax Burden | 1.00 | 1.06 | 1.12 | 1.23 | 1.00 |
| Interest Burden | 1.06 | 1.01 | 0.97 | -0.39 | 2.25 |
| Research & Development to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A to Revenue | 0.35 | 0.43 | 0.11 | 0.10 | 0.21 |
| Stock-Based Compensation to Revenue | 0.02 | 0.14 | 0.00 | 0.00 | 0.00 |
| Income Quality | 0.59 | 0.46 | 0.50 | -1.43 | 1.13 |
Currency in USD